nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—CHRM2—Dimenhydrinate—atopic dermatitis	0.288	0.401	CbGbCtD
Solifenacin—CHRM2—Diphenhydramine—atopic dermatitis	0.141	0.196	CbGbCtD
Solifenacin—CYP3A4—Pimecrolimus—atopic dermatitis	0.0749	0.104	CbGbCtD
Solifenacin—CYP3A4—Tacrolimus—atopic dermatitis	0.0445	0.0619	CbGbCtD
Solifenacin—CYP3A4—Loratadine—atopic dermatitis	0.0326	0.0453	CbGbCtD
Solifenacin—CYP3A4—Methylprednisolone—atopic dermatitis	0.0298	0.0415	CbGbCtD
Solifenacin—CYP3A4—Triamcinolone—atopic dermatitis	0.0226	0.0314	CbGbCtD
Solifenacin—CYP3A4—Betamethasone—atopic dermatitis	0.0194	0.027	CbGbCtD
Solifenacin—CYP3A4—Prednisolone—atopic dermatitis	0.0191	0.0266	CbGbCtD
Solifenacin—CYP3A4—Hydrocortisone—atopic dermatitis	0.0181	0.0252	CbGbCtD
Solifenacin—CYP3A4—Prednisone—atopic dermatitis	0.0181	0.0251	CbGbCtD
Solifenacin—CYP3A4—Dexamethasone—atopic dermatitis	0.0113	0.0157	CbGbCtD
Solifenacin—Palpitations—Tacrolimus—atopic dermatitis	0.000486	0.00187	CcSEcCtD
Solifenacin—Cough—Tacrolimus—atopic dermatitis	0.00048	0.00185	CcSEcCtD
Solifenacin—Hypertension—Tacrolimus—atopic dermatitis	0.000474	0.00183	CcSEcCtD
Solifenacin—Muscular weakness—Triamcinolone—atopic dermatitis	0.000473	0.00183	CcSEcCtD
Solifenacin—Muscular weakness—Methylprednisolone—atopic dermatitis	0.000472	0.00182	CcSEcCtD
Solifenacin—Asthenia—Loratadine—atopic dermatitis	0.000471	0.00182	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000465	0.00179	CcSEcCtD
Solifenacin—Influenza—Triamcinolone—atopic dermatitis	0.000463	0.00179	CcSEcCtD
Solifenacin—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000461	0.00178	CcSEcCtD
Solifenacin—Dry mouth—Tacrolimus—atopic dermatitis	0.000458	0.00177	CcSEcCtD
Solifenacin—Confusional state—Tacrolimus—atopic dermatitis	0.000452	0.00175	CcSEcCtD
Solifenacin—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.000449	0.00173	CcSEcCtD
Solifenacin—Dry skin—Betamethasone—atopic dermatitis	0.000446	0.00172	CcSEcCtD
Solifenacin—Dry skin—Dexamethasone—atopic dermatitis	0.000446	0.00172	CcSEcCtD
Solifenacin—Infection—Tacrolimus—atopic dermatitis	0.000446	0.00172	CcSEcCtD
Solifenacin—Abdominal pain—Mometasone—atopic dermatitis	0.000446	0.00172	CcSEcCtD
Solifenacin—Nervous system disorder—Tacrolimus—atopic dermatitis	0.00044	0.0017	CcSEcCtD
Solifenacin—Infestation NOS—Hydrocortisone—atopic dermatitis	0.000439	0.00169	CcSEcCtD
Solifenacin—Infestation—Hydrocortisone—atopic dermatitis	0.000439	0.00169	CcSEcCtD
Solifenacin—Tachycardia—Tacrolimus—atopic dermatitis	0.000438	0.00169	CcSEcCtD
Solifenacin—Skin disorder—Tacrolimus—atopic dermatitis	0.000436	0.00168	CcSEcCtD
Solifenacin—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000435	0.00168	CcSEcCtD
Solifenacin—Dizziness—Loratadine—atopic dermatitis	0.000434	0.00168	CcSEcCtD
Solifenacin—Muscular weakness—Betamethasone—atopic dermatitis	0.000429	0.00166	CcSEcCtD
Solifenacin—Muscular weakness—Dexamethasone—atopic dermatitis	0.000429	0.00166	CcSEcCtD
Solifenacin—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000418	0.00161	CcSEcCtD
Solifenacin—Vomiting—Loratadine—atopic dermatitis	0.000418	0.00161	CcSEcCtD
Solifenacin—Rash—Loratadine—atopic dermatitis	0.000414	0.0016	CcSEcCtD
Solifenacin—Dermatitis—Loratadine—atopic dermatitis	0.000414	0.0016	CcSEcCtD
Solifenacin—Infestation NOS—Methylprednisolone—atopic dermatitis	0.000412	0.00159	CcSEcCtD
Solifenacin—Infestation—Methylprednisolone—atopic dermatitis	0.000412	0.00159	CcSEcCtD
Solifenacin—Headache—Loratadine—atopic dermatitis	0.000411	0.00159	CcSEcCtD
Solifenacin—Asthenia—Mometasone—atopic dermatitis	0.000404	0.00156	CcSEcCtD
Solifenacin—Somnolence—Tacrolimus—atopic dermatitis	0.000399	0.00154	CcSEcCtD
Solifenacin—Pruritus—Mometasone—atopic dermatitis	0.000399	0.00154	CcSEcCtD
Solifenacin—Dyspepsia—Tacrolimus—atopic dermatitis	0.000395	0.00152	CcSEcCtD
Solifenacin—Hallucination—Hydrocortisone—atopic dermatitis	0.000392	0.00151	CcSEcCtD
Solifenacin—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00039	0.00151	CcSEcCtD
Solifenacin—Nausea—Loratadine—atopic dermatitis	0.00039	0.00151	CcSEcCtD
Solifenacin—Decreased appetite—Tacrolimus—atopic dermatitis	0.00039	0.00151	CcSEcCtD
Solifenacin—Dry skin—Prednisone—atopic dermatitis	0.000388	0.0015	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000387	0.00149	CcSEcCtD
Solifenacin—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.000387	0.00149	CcSEcCtD
Solifenacin—Fatigue—Tacrolimus—atopic dermatitis	0.000387	0.00149	CcSEcCtD
Solifenacin—Constipation—Tacrolimus—atopic dermatitis	0.000384	0.00148	CcSEcCtD
Solifenacin—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000375	0.00145	CcSEcCtD
Solifenacin—Muscular weakness—Prednisone—atopic dermatitis	0.000374	0.00144	CcSEcCtD
Solifenacin—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000372	0.00144	CcSEcCtD
Solifenacin—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000372	0.00144	CcSEcCtD
Solifenacin—Headache—Fluocinolone Acetonide—atopic dermatitis	0.00037	0.00143	CcSEcCtD
Solifenacin—Feeling abnormal—Tacrolimus—atopic dermatitis	0.00037	0.00143	CcSEcCtD
Solifenacin—Hallucination—Methylprednisolone—atopic dermatitis	0.000368	0.00142	CcSEcCtD
Solifenacin—Pharyngitis—Triamcinolone—atopic dermatitis	0.000368	0.00142	CcSEcCtD
Solifenacin—Eye disorder—Hydrocortisone—atopic dermatitis	0.000368	0.00142	CcSEcCtD
Solifenacin—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000367	0.00142	CcSEcCtD
Solifenacin—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000364	0.0014	CcSEcCtD
Solifenacin—Vomiting—Mometasone—atopic dermatitis	0.000358	0.00138	CcSEcCtD
Solifenacin—Urticaria—Tacrolimus—atopic dermatitis	0.000356	0.00138	CcSEcCtD
Solifenacin—Immune system disorder—Hydrocortisone—atopic dermatitis	0.000356	0.00137	CcSEcCtD
Solifenacin—Rash—Mometasone—atopic dermatitis	0.000355	0.00137	CcSEcCtD
Solifenacin—Dermatitis—Mometasone—atopic dermatitis	0.000355	0.00137	CcSEcCtD
Solifenacin—Abdominal pain—Tacrolimus—atopic dermatitis	0.000355	0.00137	CcSEcCtD
Solifenacin—Headache—Mometasone—atopic dermatitis	0.000353	0.00136	CcSEcCtD
Solifenacin—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000351	0.00135	CcSEcCtD
Solifenacin—Eye disorder—Methylprednisolone—atopic dermatitis	0.000346	0.00133	CcSEcCtD
Solifenacin—Mental disorder—Hydrocortisone—atopic dermatitis	0.000345	0.00133	CcSEcCtD
Solifenacin—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000343	0.00133	CcSEcCtD
Solifenacin—Malnutrition—Hydrocortisone—atopic dermatitis	0.000343	0.00132	CcSEcCtD
Solifenacin—Angiopathy—Methylprednisolone—atopic dermatitis	0.000336	0.0013	CcSEcCtD
Solifenacin—Hallucination—Dexamethasone—atopic dermatitis	0.000335	0.00129	CcSEcCtD
Solifenacin—Hallucination—Betamethasone—atopic dermatitis	0.000335	0.00129	CcSEcCtD
Solifenacin—Nausea—Mometasone—atopic dermatitis	0.000335	0.00129	CcSEcCtD
Solifenacin—Immune system disorder—Methylprednisolone—atopic dermatitis	0.000334	0.00129	CcSEcCtD
Solifenacin—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000333	0.00129	CcSEcCtD
Solifenacin—Vision blurred—Prednisolone—atopic dermatitis	0.000331	0.00128	CcSEcCtD
Solifenacin—Hypersensitivity—Tacrolimus—atopic dermatitis	0.00033	0.00128	CcSEcCtD
Solifenacin—Depression—Prednisone—atopic dermatitis	0.000325	0.00126	CcSEcCtD
Solifenacin—Mental disorder—Methylprednisolone—atopic dermatitis	0.000324	0.00125	CcSEcCtD
Solifenacin—Malnutrition—Methylprednisolone—atopic dermatitis	0.000322	0.00124	CcSEcCtD
Solifenacin—Asthenia—Tacrolimus—atopic dermatitis	0.000322	0.00124	CcSEcCtD
Solifenacin—Angioedema—Prednisolone—atopic dermatitis	0.000321	0.00124	CcSEcCtD
Solifenacin—Pruritus—Tacrolimus—atopic dermatitis	0.000317	0.00123	CcSEcCtD
Solifenacin—Dysgeusia—Triamcinolone—atopic dermatitis	0.000316	0.00122	CcSEcCtD
Solifenacin—Eye disorder—Dexamethasone—atopic dermatitis	0.000314	0.00121	CcSEcCtD
Solifenacin—Eye disorder—Betamethasone—atopic dermatitis	0.000314	0.00121	CcSEcCtD
Solifenacin—Angioedema—Hydrocortisone—atopic dermatitis	0.000313	0.00121	CcSEcCtD
Solifenacin—Angiopathy—Betamethasone—atopic dermatitis	0.000305	0.00118	CcSEcCtD
Solifenacin—Angiopathy—Dexamethasone—atopic dermatitis	0.000305	0.00118	CcSEcCtD
Solifenacin—Hypertension—Prednisolone—atopic dermatitis	0.000303	0.00117	CcSEcCtD
Solifenacin—Dizziness—Tacrolimus—atopic dermatitis	0.000297	0.00114	CcSEcCtD
Solifenacin—Hypertension—Hydrocortisone—atopic dermatitis	0.000296	0.00114	CcSEcCtD
Solifenacin—Angioedema—Triamcinolone—atopic dermatitis	0.000295	0.00114	CcSEcCtD
Solifenacin—Angioedema—Methylprednisolone—atopic dermatitis	0.000294	0.00114	CcSEcCtD
Solifenacin—Hallucination—Prednisone—atopic dermatitis	0.000292	0.00113	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.00029	0.00112	CcSEcCtD
Solifenacin—Connective tissue disorder—Prednisone—atopic dermatitis	0.000288	0.00111	CcSEcCtD
Solifenacin—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000286	0.00111	CcSEcCtD
Solifenacin—Vomiting—Tacrolimus—atopic dermatitis	0.000285	0.0011	CcSEcCtD
Solifenacin—Rash—Tacrolimus—atopic dermatitis	0.000283	0.00109	CcSEcCtD
Solifenacin—Dermatitis—Tacrolimus—atopic dermatitis	0.000283	0.00109	CcSEcCtD
Solifenacin—Cough—Triamcinolone—atopic dermatitis	0.000282	0.00109	CcSEcCtD
Solifenacin—Headache—Tacrolimus—atopic dermatitis	0.000281	0.00108	CcSEcCtD
Solifenacin—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.00028	0.00108	CcSEcCtD
Solifenacin—Tachycardia—Prednisolone—atopic dermatitis	0.00028	0.00108	CcSEcCtD
Solifenacin—Hypertension—Triamcinolone—atopic dermatitis	0.000279	0.00108	CcSEcCtD
Solifenacin—Hypertension—Methylprednisolone—atopic dermatitis	0.000278	0.00107	CcSEcCtD
Solifenacin—Infection—Hydrocortisone—atopic dermatitis	0.000278	0.00107	CcSEcCtD
Solifenacin—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000274	0.00106	CcSEcCtD
Solifenacin—Eye disorder—Prednisone—atopic dermatitis	0.000274	0.00106	CcSEcCtD
Solifenacin—Tachycardia—Hydrocortisone—atopic dermatitis	0.000273	0.00105	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000272	0.00105	CcSEcCtD
Solifenacin—Skin disorder—Hydrocortisone—atopic dermatitis	0.000272	0.00105	CcSEcCtD
Solifenacin—Dry mouth—Triamcinolone—atopic dermatitis	0.000269	0.00104	CcSEcCtD
Solifenacin—Angioedema—Betamethasone—atopic dermatitis	0.000268	0.00103	CcSEcCtD
Solifenacin—Angioedema—Dexamethasone—atopic dermatitis	0.000268	0.00103	CcSEcCtD
Solifenacin—Nausea—Tacrolimus—atopic dermatitis	0.000266	0.00103	CcSEcCtD
Solifenacin—Angiopathy—Prednisone—atopic dermatitis	0.000266	0.00103	CcSEcCtD
Solifenacin—Confusional state—Methylprednisolone—atopic dermatitis	0.000265	0.00102	CcSEcCtD
Solifenacin—Immune system disorder—Prednisone—atopic dermatitis	0.000265	0.00102	CcSEcCtD
Solifenacin—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000263	0.00102	CcSEcCtD
Solifenacin—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000263	0.00101	CcSEcCtD
Solifenacin—Infection—Triamcinolone—atopic dermatitis	0.000262	0.00101	CcSEcCtD
Solifenacin—Infection—Methylprednisolone—atopic dermatitis	0.000261	0.00101	CcSEcCtD
Solifenacin—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000258	0.000995	CcSEcCtD
Solifenacin—Tachycardia—Triamcinolone—atopic dermatitis	0.000257	0.000993	CcSEcCtD
Solifenacin—Mental disorder—Prednisone—atopic dermatitis	0.000257	0.000991	CcSEcCtD
Solifenacin—Tachycardia—Methylprednisolone—atopic dermatitis	0.000257	0.00099	CcSEcCtD
Solifenacin—Skin disorder—Methylprednisolone—atopic dermatitis	0.000255	0.000986	CcSEcCtD
Solifenacin—Malnutrition—Prednisone—atopic dermatitis	0.000255	0.000985	CcSEcCtD
Solifenacin—Hypertension—Dexamethasone—atopic dermatitis	0.000253	0.000976	CcSEcCtD
Solifenacin—Hypertension—Betamethasone—atopic dermatitis	0.000253	0.000976	CcSEcCtD
Solifenacin—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000246	0.000951	CcSEcCtD
Solifenacin—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000243	0.000939	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000242	0.000933	CcSEcCtD
Solifenacin—Fatigue—Hydrocortisone—atopic dermatitis	0.000241	0.000931	CcSEcCtD
Solifenacin—Vision blurred—Prednisone—atopic dermatitis	0.00024	0.000928	CcSEcCtD
Solifenacin—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000239	0.000923	CcSEcCtD
Solifenacin—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000239	0.000923	CcSEcCtD
Solifenacin—Infection—Betamethasone—atopic dermatitis	0.000237	0.000917	CcSEcCtD
Solifenacin—Infection—Dexamethasone—atopic dermatitis	0.000237	0.000917	CcSEcCtD
Solifenacin—Feeling abnormal—Prednisolone—atopic dermatitis	0.000236	0.000911	CcSEcCtD
Solifenacin—Nervous system disorder—Betamethasone—atopic dermatitis	0.000234	0.000905	CcSEcCtD
Solifenacin—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000234	0.000905	CcSEcCtD
Solifenacin—Tachycardia—Dexamethasone—atopic dermatitis	0.000233	0.000901	CcSEcCtD
Solifenacin—Tachycardia—Betamethasone—atopic dermatitis	0.000233	0.000901	CcSEcCtD
Solifenacin—Angioedema—Prednisone—atopic dermatitis	0.000233	0.0009	CcSEcCtD
Solifenacin—Dyspepsia—Triamcinolone—atopic dermatitis	0.000232	0.000895	CcSEcCtD
Solifenacin—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000231	0.000893	CcSEcCtD
Solifenacin—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000231	0.00089	CcSEcCtD
Solifenacin—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000229	0.000883	CcSEcCtD
Solifenacin—Urticaria—Prednisolone—atopic dermatitis	0.000228	0.000879	CcSEcCtD
Solifenacin—Fatigue—Triamcinolone—atopic dermatitis	0.000227	0.000877	CcSEcCtD
Solifenacin—Fatigue—Methylprednisolone—atopic dermatitis	0.000227	0.000875	CcSEcCtD
Solifenacin—Urticaria—Hydrocortisone—atopic dermatitis	0.000222	0.000858	CcSEcCtD
Solifenacin—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000221	0.000854	CcSEcCtD
Solifenacin—Hypertension—Prednisone—atopic dermatitis	0.00022	0.00085	CcSEcCtD
Solifenacin—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000217	0.000838	CcSEcCtD
Solifenacin—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000217	0.000836	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000216	0.000833	CcSEcCtD
Solifenacin—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000215	0.00083	CcSEcCtD
Solifenacin—Hypersensitivity—Prednisolone—atopic dermatitis	0.000211	0.000815	CcSEcCtD
Solifenacin—Dyspepsia—Betamethasone—atopic dermatitis	0.00021	0.000812	CcSEcCtD
Solifenacin—Dyspepsia—Dexamethasone—atopic dermatitis	0.00021	0.000812	CcSEcCtD
Solifenacin—Urticaria—Triamcinolone—atopic dermatitis	0.000209	0.000808	CcSEcCtD
Solifenacin—Urticaria—Methylprednisolone—atopic dermatitis	0.000209	0.000806	CcSEcCtD
Solifenacin—Anaphylactic shock—Prednisone—atopic dermatitis	0.000208	0.000804	CcSEcCtD
Solifenacin—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000208	0.000802	CcSEcCtD
Solifenacin—Decreased appetite—Betamethasone—atopic dermatitis	0.000208	0.000802	CcSEcCtD
Solifenacin—Decreased appetite—Dexamethasone—atopic dermatitis	0.000208	0.000802	CcSEcCtD
Solifenacin—Infection—Prednisone—atopic dermatitis	0.000207	0.000798	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000206	0.000797	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000206	0.000797	CcSEcCtD
Solifenacin—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000206	0.000796	CcSEcCtD
Solifenacin—Fatigue—Dexamethasone—atopic dermatitis	0.000206	0.000796	CcSEcCtD
Solifenacin—Fatigue—Betamethasone—atopic dermatitis	0.000206	0.000796	CcSEcCtD
Solifenacin—Nervous system disorder—Prednisone—atopic dermatitis	0.000204	0.000788	CcSEcCtD
Solifenacin—Tachycardia—Prednisone—atopic dermatitis	0.000203	0.000784	CcSEcCtD
Solifenacin—Skin disorder—Prednisone—atopic dermatitis	0.000202	0.000781	CcSEcCtD
Solifenacin—Asthenia—Hydrocortisone—atopic dermatitis	0.000201	0.000775	CcSEcCtD
Solifenacin—Pruritus—Hydrocortisone—atopic dermatitis	0.000198	0.000764	CcSEcCtD
Solifenacin—Feeling abnormal—Betamethasone—atopic dermatitis	0.000197	0.00076	CcSEcCtD
Solifenacin—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000197	0.00076	CcSEcCtD
Solifenacin—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000195	0.000755	CcSEcCtD
Solifenacin—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000195	0.000755	CcSEcCtD
Solifenacin—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000194	0.000749	CcSEcCtD
Solifenacin—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000194	0.000748	CcSEcCtD
Solifenacin—Urticaria—Betamethasone—atopic dermatitis	0.00019	0.000733	CcSEcCtD
Solifenacin—Urticaria—Dexamethasone—atopic dermatitis	0.00019	0.000733	CcSEcCtD
Solifenacin—Dizziness—Prednisolone—atopic dermatitis	0.000189	0.000731	CcSEcCtD
Solifenacin—Asthenia—Triamcinolone—atopic dermatitis	0.000189	0.00073	CcSEcCtD
Solifenacin—Abdominal pain—Betamethasone—atopic dermatitis	0.000189	0.00073	CcSEcCtD
Solifenacin—Abdominal pain—Dexamethasone—atopic dermatitis	0.000189	0.00073	CcSEcCtD
Solifenacin—Asthenia—Methylprednisolone—atopic dermatitis	0.000189	0.000728	CcSEcCtD
Solifenacin—Pruritus—Triamcinolone—atopic dermatitis	0.000186	0.00072	CcSEcCtD
Solifenacin—Pruritus—Methylprednisolone—atopic dermatitis	0.000186	0.000718	CcSEcCtD
Solifenacin—Dizziness—Hydrocortisone—atopic dermatitis	0.000185	0.000714	CcSEcCtD
Solifenacin—Dyspepsia—Prednisone—atopic dermatitis	0.000183	0.000707	CcSEcCtD
Solifenacin—Decreased appetite—Prednisone—atopic dermatitis	0.000181	0.000699	CcSEcCtD
Solifenacin—Rash—Prednisolone—atopic dermatitis	0.000181	0.000697	CcSEcCtD
Solifenacin—Dermatitis—Prednisolone—atopic dermatitis	0.00018	0.000697	CcSEcCtD
Solifenacin—Fatigue—Prednisone—atopic dermatitis	0.000179	0.000693	CcSEcCtD
Solifenacin—Headache—Prednisolone—atopic dermatitis	0.000179	0.000693	CcSEcCtD
Solifenacin—Constipation—Prednisone—atopic dermatitis	0.000178	0.000687	CcSEcCtD
Solifenacin—Vomiting—Hydrocortisone—atopic dermatitis	0.000178	0.000687	CcSEcCtD
Solifenacin—Rash—Hydrocortisone—atopic dermatitis	0.000176	0.000681	CcSEcCtD
Solifenacin—Dermatitis—Hydrocortisone—atopic dermatitis	0.000176	0.00068	CcSEcCtD
Solifenacin—Headache—Hydrocortisone—atopic dermatitis	0.000175	0.000677	CcSEcCtD
Solifenacin—Dizziness—Triamcinolone—atopic dermatitis	0.000174	0.000673	CcSEcCtD
Solifenacin—Dizziness—Methylprednisolone—atopic dermatitis	0.000174	0.000671	CcSEcCtD
Solifenacin—Feeling abnormal—Prednisone—atopic dermatitis	0.000172	0.000662	CcSEcCtD
Solifenacin—Asthenia—Betamethasone—atopic dermatitis	0.000172	0.000662	CcSEcCtD
Solifenacin—Asthenia—Dexamethasone—atopic dermatitis	0.000172	0.000662	CcSEcCtD
Solifenacin—Gastrointestinal pain—Prednisone—atopic dermatitis	0.00017	0.000657	CcSEcCtD
Solifenacin—Nausea—Prednisolone—atopic dermatitis	0.00017	0.000657	CcSEcCtD
Solifenacin—Pruritus—Dexamethasone—atopic dermatitis	0.000169	0.000653	CcSEcCtD
Solifenacin—Pruritus—Betamethasone—atopic dermatitis	0.000169	0.000653	CcSEcCtD
Solifenacin—Vomiting—Triamcinolone—atopic dermatitis	0.000168	0.000647	CcSEcCtD
Solifenacin—Vomiting—Methylprednisolone—atopic dermatitis	0.000167	0.000645	CcSEcCtD
Solifenacin—Nausea—Hydrocortisone—atopic dermatitis	0.000166	0.000642	CcSEcCtD
Solifenacin—Rash—Triamcinolone—atopic dermatitis	0.000166	0.000641	CcSEcCtD
Solifenacin—Dermatitis—Triamcinolone—atopic dermatitis	0.000166	0.000641	CcSEcCtD
Solifenacin—Rash—Methylprednisolone—atopic dermatitis	0.000166	0.00064	CcSEcCtD
Solifenacin—Dermatitis—Methylprednisolone—atopic dermatitis	0.000166	0.000639	CcSEcCtD
Solifenacin—Urticaria—Prednisone—atopic dermatitis	0.000165	0.000638	CcSEcCtD
Solifenacin—Headache—Triamcinolone—atopic dermatitis	0.000165	0.000637	CcSEcCtD
Solifenacin—Headache—Methylprednisolone—atopic dermatitis	0.000165	0.000636	CcSEcCtD
Solifenacin—Abdominal pain—Prednisone—atopic dermatitis	0.000165	0.000635	CcSEcCtD
Solifenacin—Dizziness—Dexamethasone—atopic dermatitis	0.000158	0.00061	CcSEcCtD
Solifenacin—Dizziness—Betamethasone—atopic dermatitis	0.000158	0.00061	CcSEcCtD
Solifenacin—Nausea—Triamcinolone—atopic dermatitis	0.000156	0.000604	CcSEcCtD
Solifenacin—Nausea—Methylprednisolone—atopic dermatitis	0.000156	0.000603	CcSEcCtD
Solifenacin—Hypersensitivity—Prednisone—atopic dermatitis	0.000153	0.000592	CcSEcCtD
Solifenacin—Vomiting—Dexamethasone—atopic dermatitis	0.000152	0.000587	CcSEcCtD
Solifenacin—Vomiting—Betamethasone—atopic dermatitis	0.000152	0.000587	CcSEcCtD
Solifenacin—Rash—Betamethasone—atopic dermatitis	0.000151	0.000582	CcSEcCtD
Solifenacin—Rash—Dexamethasone—atopic dermatitis	0.000151	0.000582	CcSEcCtD
Solifenacin—Dermatitis—Dexamethasone—atopic dermatitis	0.000151	0.000581	CcSEcCtD
Solifenacin—Dermatitis—Betamethasone—atopic dermatitis	0.000151	0.000581	CcSEcCtD
Solifenacin—Headache—Dexamethasone—atopic dermatitis	0.00015	0.000578	CcSEcCtD
Solifenacin—Headache—Betamethasone—atopic dermatitis	0.00015	0.000578	CcSEcCtD
Solifenacin—Asthenia—Prednisone—atopic dermatitis	0.000149	0.000577	CcSEcCtD
Solifenacin—Pruritus—Prednisone—atopic dermatitis	0.000147	0.000569	CcSEcCtD
Solifenacin—Nausea—Betamethasone—atopic dermatitis	0.000142	0.000548	CcSEcCtD
Solifenacin—Nausea—Dexamethasone—atopic dermatitis	0.000142	0.000548	CcSEcCtD
Solifenacin—Dizziness—Prednisone—atopic dermatitis	0.000138	0.000531	CcSEcCtD
Solifenacin—Vomiting—Prednisone—atopic dermatitis	0.000132	0.000511	CcSEcCtD
Solifenacin—Rash—Prednisone—atopic dermatitis	0.000131	0.000507	CcSEcCtD
Solifenacin—Dermatitis—Prednisone—atopic dermatitis	0.000131	0.000506	CcSEcCtD
Solifenacin—Headache—Prednisone—atopic dermatitis	0.00013	0.000503	CcSEcCtD
Solifenacin—Nausea—Prednisone—atopic dermatitis	0.000124	0.000477	CcSEcCtD
Solifenacin—CHRM4—Signaling Pathways—CCL27—atopic dermatitis	4.5e-05	0.00204	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CCR3—atopic dermatitis	4.49e-05	0.00203	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	4.42e-05	0.002	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—TAC1—atopic dermatitis	4.41e-05	0.00199	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—NPS—atopic dermatitis	4.41e-05	0.00199	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—CXCR3—atopic dermatitis	4.32e-05	0.00196	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCL27—atopic dermatitis	4.31e-05	0.00195	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CCR3—atopic dermatitis	4.3e-05	0.00195	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	4.25e-05	0.00192	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	4.24e-05	0.00192	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	4.23e-05	0.00192	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—NPS—atopic dermatitis	4.22e-05	0.00191	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—TAC1—atopic dermatitis	4.22e-05	0.00191	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	4.19e-05	0.0019	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—CXCL10—atopic dermatitis	4.17e-05	0.00189	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—CXCL10—atopic dermatitis	4.16e-05	0.00188	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—CXCR3—atopic dermatitis	4.14e-05	0.00187	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—CXCL10—atopic dermatitis	4.12e-05	0.00186	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—IL5—atopic dermatitis	4.1e-05	0.00185	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCL17—atopic dermatitis	4.04e-05	0.00183	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—NPS—atopic dermatitis	4e-05	0.00181	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—TAC1—atopic dermatitis	4e-05	0.00181	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CXCR3—atopic dermatitis	3.93e-05	0.00178	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—IL5—atopic dermatitis	3.93e-05	0.00178	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCL17—atopic dermatitis	3.87e-05	0.00175	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—NPS—atopic dermatitis	3.83e-05	0.00173	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—TAC1—atopic dermatitis	3.83e-05	0.00173	CbGpPWpGaD
Solifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.81e-05	0.00172	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CXCR3—atopic dermatitis	3.76e-05	0.0017	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL5—atopic dermatitis	3.72e-05	0.00168	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CCL11—atopic dermatitis	3.72e-05	0.00168	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CCL11—atopic dermatitis	3.7e-05	0.00168	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CCL11—atopic dermatitis	3.67e-05	0.00166	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—FCER2—atopic dermatitis	3.66e-05	0.00166	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—FCER2—atopic dermatitis	3.65e-05	0.00165	CbGpPWpGaD
Solifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.65e-05	0.00165	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FCER2—atopic dermatitis	3.62e-05	0.00164	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—KIF3A—atopic dermatitis	3.6e-05	0.00163	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—CCL5—atopic dermatitis	3.59e-05	0.00162	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—CCL5—atopic dermatitis	3.58e-05	0.00162	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL5—atopic dermatitis	3.56e-05	0.00161	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—CCL5—atopic dermatitis	3.54e-05	0.0016	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—CXCL10—atopic dermatitis	3.49e-05	0.00158	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GLB1—atopic dermatitis	3.45e-05	0.00156	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—KIF3A—atopic dermatitis	3.45e-05	0.00156	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCL22—atopic dermatitis	3.41e-05	0.00154	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCL22—atopic dermatitis	3.4e-05	0.00154	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCL22—atopic dermatitis	3.36e-05	0.00152	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—CXCL10—atopic dermatitis	3.35e-05	0.00151	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CCR3—atopic dermatitis	3.34e-05	0.00151	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CCR3—atopic dermatitis	3.32e-05	0.0015	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ADSL—atopic dermatitis	3.31e-05	0.0015	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CCR3—atopic dermatitis	3.29e-05	0.00149	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CMA1—atopic dermatitis	3.26e-05	0.00147	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCL11—atopic dermatitis	3.26e-05	0.00147	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—CCR5—atopic dermatitis	3.23e-05	0.00146	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—CCR5—atopic dermatitis	3.22e-05	0.00146	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—MAPK8—atopic dermatitis	3.22e-05	0.00146	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—CCR5—atopic dermatitis	3.19e-05	0.00144	CbGpPWpGaD
Solifenacin—CHRM2—G alpha (i) signalling events—CXCL8—atopic dermatitis	3.19e-05	0.00144	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CXCL10—atopic dermatitis	3.17e-05	0.00144	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CMA1—atopic dermatitis	3.12e-05	0.00141	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCL11—atopic dermatitis	3.12e-05	0.00141	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	3.08e-05	0.00139	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—STAT6—atopic dermatitis	3.06e-05	0.00138	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CXCL10—atopic dermatitis	3.04e-05	0.00138	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCL27—atopic dermatitis	3.04e-05	0.00137	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CCR3—atopic dermatitis	3.03e-05	0.00137	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCL27—atopic dermatitis	3.03e-05	0.00137	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CCR3—atopic dermatitis	3.02e-05	0.00137	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—CCL5—atopic dermatitis	3.01e-05	0.00136	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCL27—atopic dermatitis	3e-05	0.00136	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CCR3—atopic dermatitis	2.99e-05	0.00135	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—TAC1—atopic dermatitis	2.97e-05	0.00135	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—NPS—atopic dermatitis	2.97e-05	0.00135	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—TAC1—atopic dermatitis	2.96e-05	0.00134	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—NPS—atopic dermatitis	2.96e-05	0.00134	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—TAC1—atopic dermatitis	2.93e-05	0.00133	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—NPS—atopic dermatitis	2.93e-05	0.00133	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—STAT6—atopic dermatitis	2.93e-05	0.00133	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	2.92e-05	0.00132	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CXCR3—atopic dermatitis	2.91e-05	0.00131	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—CXCL8—atopic dermatitis	2.9e-05	0.00131	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—CCL5—atopic dermatitis	2.88e-05	0.0013	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CXCR3—atopic dermatitis	2.88e-05	0.0013	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—CXCL8—atopic dermatitis	2.78e-05	0.00126	CbGpPWpGaD
Solifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.77e-05	0.00125	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—IL5—atopic dermatitis	2.76e-05	0.00125	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—IL5—atopic dermatitis	2.75e-05	0.00125	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CCL5—atopic dermatitis	2.73e-05	0.00124	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—IL5—atopic dermatitis	2.73e-05	0.00123	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCL17—atopic dermatitis	2.72e-05	0.00123	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCL17—atopic dermatitis	2.71e-05	0.00123	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—CCR5—atopic dermatitis	2.71e-05	0.00123	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—TAC1—atopic dermatitis	2.7e-05	0.00122	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—NPS—atopic dermatitis	2.7e-05	0.00122	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—TAC1—atopic dermatitis	2.69e-05	0.00122	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—NPS—atopic dermatitis	2.69e-05	0.00122	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCL17—atopic dermatitis	2.69e-05	0.00122	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—TAC1—atopic dermatitis	2.66e-05	0.00121	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—NPS—atopic dermatitis	2.66e-05	0.00121	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCR3—atopic dermatitis	2.65e-05	0.0012	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CXCR3—atopic dermatitis	2.65e-05	0.0012	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CXCR3—atopic dermatitis	2.64e-05	0.00119	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CCL5—atopic dermatitis	2.62e-05	0.00118	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CXCR3—atopic dermatitis	2.61e-05	0.00118	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—CCR5—atopic dermatitis	2.6e-05	0.00117	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.57e-05	0.00116	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.56e-05	0.00116	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCR3—atopic dermatitis	2.54e-05	0.00115	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.53e-05	0.00115	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL5—atopic dermatitis	2.51e-05	0.00114	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL5—atopic dermatitis	2.5e-05	0.00113	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	2.49e-05	0.00112	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL5—atopic dermatitis	2.48e-05	0.00112	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CCR5—atopic dermatitis	2.46e-05	0.00111	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—KIF3A—atopic dermatitis	2.43e-05	0.0011	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—KIF3A—atopic dermatitis	2.42e-05	0.00109	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—KIF3A—atopic dermatitis	2.4e-05	0.00108	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NPS—atopic dermatitis	2.37e-05	0.00107	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TAC1—atopic dermatitis	2.37e-05	0.00107	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CCR5—atopic dermatitis	2.36e-05	0.00107	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	2.36e-05	0.00107	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CXCL10—atopic dermatitis	2.35e-05	0.00106	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CXCL10—atopic dermatitis	2.33e-05	0.00105	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CXCR3—atopic dermatitis	2.32e-05	0.00105	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TAC1—atopic dermatitis	2.26e-05	0.00102	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NPS—atopic dermatitis	2.26e-05	0.00102	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CXCR3—atopic dermatitis	2.22e-05	0.00101	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL5—atopic dermatitis	2.2e-05	0.000995	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCL11—atopic dermatitis	2.19e-05	0.000993	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CMA1—atopic dermatitis	2.19e-05	0.000993	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCL11—atopic dermatitis	2.19e-05	0.00099	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CMA1—atopic dermatitis	2.19e-05	0.00099	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCL11—atopic dermatitis	2.17e-05	0.00098	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CMA1—atopic dermatitis	2.17e-05	0.00098	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CXCL10—atopic dermatitis	2.14e-05	0.000968	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CXCL10—atopic dermatitis	2.13e-05	0.000965	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CXCL10—atopic dermatitis	2.11e-05	0.000956	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL5—atopic dermatitis	2.11e-05	0.000953	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—STAT6—atopic dermatitis	2.06e-05	0.000934	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—STAT6—atopic dermatitis	2.06e-05	0.000931	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—IL6—atopic dermatitis	2.06e-05	0.00093	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—STAT6—atopic dermatitis	2.04e-05	0.000922	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CCL5—atopic dermatitis	2.03e-05	0.000918	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CCL5—atopic dermatitis	2.02e-05	0.000915	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CCL5—atopic dermatitis	2e-05	0.000906	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—CXCL8—atopic dermatitis	1.96e-05	0.000885	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—CXCL8—atopic dermatitis	1.95e-05	0.000882	CbGpPWpGaD
Solifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.95e-05	0.000881	CbGpPWpGaD
Solifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.94e-05	0.000878	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—CXCL8—atopic dermatitis	1.93e-05	0.000873	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CXCL10—atopic dermatitis	1.87e-05	0.000848	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CCL5—atopic dermatitis	1.84e-05	0.000834	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CCL5—atopic dermatitis	1.84e-05	0.000831	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CCR5—atopic dermatitis	1.83e-05	0.000827	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CCR5—atopic dermatitis	1.82e-05	0.000824	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CCL5—atopic dermatitis	1.82e-05	0.000823	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CCR5—atopic dermatitis	1.8e-05	0.000816	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CXCL10—atopic dermatitis	1.8e-05	0.000812	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCR3—atopic dermatitis	1.79e-05	0.00081	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCR3—atopic dermatitis	1.78e-05	0.000807	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCR3—atopic dermatitis	1.77e-05	0.000799	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	1.66e-05	0.000751	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CCR5—atopic dermatitis	1.65e-05	0.000749	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—CXCL8—atopic dermatitis	1.64e-05	0.000741	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CCR5—atopic dermatitis	1.64e-05	0.000741	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCL5—atopic dermatitis	1.61e-05	0.00073	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NPS—atopic dermatitis	1.59e-05	0.000722	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	1.59e-05	0.000722	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NPS—atopic dermatitis	1.59e-05	0.000719	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TAC1—atopic dermatitis	1.59e-05	0.000719	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TAC1—atopic dermatitis	1.57e-05	0.000712	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NPS—atopic dermatitis	1.57e-05	0.000712	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—CXCL8—atopic dermatitis	1.57e-05	0.00071	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—IL2—atopic dermatitis	1.57e-05	0.000709	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	1.56e-05	0.000708	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCR3—atopic dermatitis	1.56e-05	0.000705	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCL5—atopic dermatitis	1.55e-05	0.000699	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCR3—atopic dermatitis	1.54e-05	0.000699	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—IL2—atopic dermatitis	1.5e-05	0.000679	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NGF—atopic dermatitis	1.49e-05	0.000676	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CXCL8—atopic dermatitis	1.49e-05	0.000673	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL5—atopic dermatitis	1.48e-05	0.000671	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL5—atopic dermatitis	1.48e-05	0.000669	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL5—atopic dermatitis	1.46e-05	0.000662	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCR5—atopic dermatitis	1.45e-05	0.000658	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NGF—atopic dermatitis	1.43e-05	0.000648	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CXCL8—atopic dermatitis	1.42e-05	0.000645	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL2—atopic dermatitis	1.42e-05	0.000643	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCR5—atopic dermatitis	1.39e-05	0.00063	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL2—atopic dermatitis	1.36e-05	0.000616	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.35e-05	0.000611	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.29e-05	0.000586	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	1.26e-05	0.000572	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	1.26e-05	0.00057	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	1.25e-05	0.000565	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	1.23e-05	0.000558	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	1.18e-05	0.000534	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PPARA—atopic dermatitis	1.12e-05	0.000507	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.1e-05	0.0005	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	1.1e-05	0.000498	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.09e-05	0.000494	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	1.09e-05	0.000492	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	1.08e-05	0.000491	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	1.07e-05	0.000486	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	1.06e-05	0.000478	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	1.05e-05	0.000476	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	1.04e-05	0.000472	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NGF—atopic dermatitis	1.01e-05	0.000456	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NGF—atopic dermatitis	1e-05	0.000455	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	1e-05	0.000454	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	1e-05	0.000453	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NGF—atopic dermatitis	9.95e-06	0.00045	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	9.9e-06	0.000448	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	9.8e-06	0.000444	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	9.77e-06	0.000442	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	9.68e-06	0.000438	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	9.59e-06	0.000434	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	9.56e-06	0.000432	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	9.47e-06	0.000428	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	8.79e-06	0.000398	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	8.42e-06	0.000381	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL2—atopic dermatitis	8.4e-06	0.00038	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	8.36e-06	0.000378	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	8.31e-06	0.000376	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	8.28e-06	0.000375	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	8.2e-06	0.000371	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL2—atopic dermatitis	8.04e-06	0.000364	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	8e-06	0.000362	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	7.73e-06	0.00035	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	7.4e-06	0.000335	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	5.93e-06	0.000268	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	5.91e-06	0.000267	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	5.85e-06	0.000265	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL2—atopic dermatitis	5.66e-06	0.000256	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL2—atopic dermatitis	5.65e-06	0.000255	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	5.64e-06	0.000255	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	5.62e-06	0.000254	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL2—atopic dermatitis	5.59e-06	0.000253	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	5.56e-06	0.000252	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	5.21e-06	0.000236	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	5.2e-06	0.000235	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	5.15e-06	0.000233	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL6—atopic dermatitis	4.94e-06	0.000223	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL6—atopic dermatitis	4.73e-06	0.000214	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPARA—atopic dermatitis	4.38e-06	0.000198	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6—atopic dermatitis	3.33e-06	0.000151	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6—atopic dermatitis	3.32e-06	0.00015	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6—atopic dermatitis	3.29e-06	0.000149	CbGpPWpGaD
